Lucosky Brookman LLP Represents Joseph Gunnar & Co. in $3.25 Million Registered Direct Offering
Northwest Biotherapeutics ("NWBO"), a biotechnology company focused on developing personalized immune therapies for cancer, registered direct offering of common stock shares, facilitated by Joseph Gunnar & Co. This transaction, conducted under a shelf S-3 registration, culminated on June 5th. The shares were strategically placed with SIO Capital Management, generating substantial gross proceeds amounting to $3.25 million.
Lucosky Brookman served as counsel to Joseph Gunnar & Co., LLC, who acted as a placement agent in this registered direct offering.